It might be wise to consider adding androgen to the estrogen or estrogen-progestin regimens in the appropriate patients.
Gelfand
Morrie M
MM
D000368:Aged; D000728:Androgens / Q000627:therapeutic use*; D004338:Drug Combinations; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D008593:Menopause / Q000187:drug effects* / Q000502:physiology; D008875:Middle Aged; D017060:Patient Satisfaction; D011372:Progestins / Q000627:therapeutic use*; D011788:Quality of Life; D018570:Risk Assessment; D016896:Treatment Outcome
D000728:Androgens; D004338:Drug Combinations; D004967:Estrogens; D011372:Progestins